Home
Conditions
Hodgkin Disease

Clinical trial condition

Hodgkin Disease

Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.

958 public trials 99 recruiting studies

Refine in advanced search Browse all conditions

Hodgkin Disease trial results

Completed

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02129582

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +44 more
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

CBT on Fatigue in Survivors of Hodgkin Lymphoma

NCT03968250

Conditions: Fatigue, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations: University Medical Center Leipzig Leipzig, Saxony, Germany

University Medical Center Cologne Cologne, Germany

View Trial Details

Completed

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00536601

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT02104427

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

NCT01458288

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Stony Brook University Hospital Stony Brook, New York, United States

View Trial Details

Completed

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

NCT01990534

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: Prague, Czechia

Brno, Czechia

Heidelberg, Baden-Wurttemberg, Germany

Cologne, Germany

View all 18 locations

View Trial Details

Completed

Ibrutinib in Relapsed Nodular Lymphocyte-predominant Hodgkin Lymphoma (NLPHL)

NCT02626884

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
Locations: 1st Department of Medicine, Cologne University Hospital Cologne, Germany

View Trial Details

Completed

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

NCT00302003

Conditions: Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity Hodgkin Lymphoma, +12 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

NCT00381940

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +30 more
Locations: Children's Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma

NCT01207921

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

Wake Forest University Winston-Salem, North Carolina, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Hodgkin Disease

Hodgkin Disease trial results

Related conditions